3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
2
Lung Neoplasms
2
Recurrence
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Edema
1
Adenocarcinoma
1
Interventions
Gemcitabine
3
Ethanol
3
fish oil triglycerides
2
S 1 (combination)
2
Metronidazole
2
Long-Term Synaptic Depression
2
Dexamethasone
2
pembrolizumab
1
pasireotide
1
nimotuzumab
1
ferumoxtran-10
1
alanylglutamine
1
Tobacco Use Cessation Devices
1
TachoSil
1
Sunitinib
1
Psychiatric Rehabilitation
1
Pregabalin
1
Polymerase Chain Reaction
1
Polygeline
1
Parenteral Nutrition
1
Pancrelipase
1
Oxaliplatin
1
Nutritional Status
1
Needles
1
Mirtazapine
1
Midazolam
1
Meperidine
1
Immunonutrition Diet
1
Hydrocortisone
1
Glucocorticoids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pancreatic Neoplasms
×
Desflurane
×
Clear all
NCT02335151
2019-12-13
CTC Pancreatic Adenocarcinoma
University of Zurich
Phase 4
Completed
86 enrolled